Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Opening the door to coordination of care through teachable moments.

Berg GD, Korn AM, Thomas E, Klemka-Walden L, Bigony MD, Newman JF.

Dis Manag. 2007 Oct;10(5):285-92.

PMID:
17961081
2.

Competency-based health services management education: contemporary issues and emerging challenges.

Counte MA, Newman JF.

J Health Adm Educ. 2002 Fall;20(2):113-22.

PMID:
12625647
3.

Essential competencies in human resource management.

Counte MA, Newman JF.

J Health Adm Educ. 2001;Spec No:167-71. No abstract available.

PMID:
11805977
4.

CEO performance appraisal: review and recommendations.

Newman JF, Tyler L, Dunbar DM.

J Healthc Manag. 2001 Jan-Feb;46(1):21-37; discussion 37-8.

PMID:
11216120
5.

Managed care and ethical conflicts.

Newman JF, Dunbar DM.

Manag Care Q. 2000 Autumn;8(4):20-32.

PMID:
11146841
6.

Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.

Brown F, Benkirane N, Limal D, Halimi H, Newman JF, Van Regenmortel MH, Briand JP, Muller S.

Vaccine. 1999 Aug 20;18(1-2):50-6.

PMID:
10501234
7.

A universal virus inactivant for decontaminating blood and biopharmaceutical products.

Brown F, Meyer RF, Law M, Kramer E, Newman JF.

Dev Biol Stand. 1999;99:119-30.

PMID:
10404883
8.

Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculovirus-expressed specific proteins.

Mezencio JM, Babcock GD, Meyer RF, Lubroth J, Salt JS, Newman JF, Brown F.

Vet Q. 1998;20 Suppl 2:S11-3.

PMID:
9652055
9.

A universal virus inactivant for decontaminating blood and biopharmaceutical products.

Brown F, Meyer RF, Law M, Kramer E, Newman JF.

Biologicals. 1998 Mar;26(1):39-47.

PMID:
9637748
10.

Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculovirus-expressed specific proteins.

Mezencio JM, Babcock GD, Meyer RF, Lubroth J, Salt JS, Newman JF, Brown F.

Vet Q. 1998 May;20(sup2):11-13.

PMID:
22077289
11.

A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies.

Briand JP, Benkirane N, Guichard G, Newman JF, Van Regenmortel MH, Brown F, Muller S.

Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12545-50.

12.
13.

Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals.

Meyer RF, Babcock GD, Newman JF, Burrage TG, Toohey K, Lubroth J, Brown F.

J Virol Methods. 1997 Apr;65(1):33-43.

PMID:
9128860
14.

The cost of poor birth outcomes in employer-sponsored health plans.

Chollet DJ, Newman JF Jr, Sumner AT.

Med Care. 1996 Dec;34(12):1219-34.

PMID:
8962588
15.
16.

Stabilising oral poliovaccine at high ambient temperatures.

Newman JF, Tirrell S, Ullman C, Piatti PG, Brown F.

Dev Biol Stand. 1996;87:103-11. Review.

PMID:
8854007
17.

Characterization of an acid-resistant mutant of foot-and-mouth disease virus.

Twomey T, France LL, Hassard S, Burrage TG, Newman JF, Brown F.

Virology. 1995 Jan 10;206(1):69-75.

18.

Stabilising oral poliovaccine at high ambient temperatures.

Newman JF, Tirrell S, Ullman C, Piatti PG, Brown F.

Vaccine. 1995;13(15):1431-5.

PMID:
8578821
19.

Antigenic variants in a plaque-isolate of foot-and-mouth disease virus: implications for vaccine production.

Piatti P, Hassard S, Newman JF, Brown F.

Vaccine. 1995;13(8):781-4. Review.

PMID:
7483796
20.

Function of minor polypeptides in foot-and-mouth disease virus and poliovirus.

Newman JF, Piatti PG, Ryan MD, Brown F.

Trends Microbiol. 1994 Dec;2(12):494-7.

PMID:
7889327
21.
22.

Foot-and-mouth disease virus particles contain replicase protein 3D.

Newman JF, Piatti PG, Gorman BM, Burrage TG, Ryan MD, Flint M, Brown F.

Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):733-7.

23.
24.

Regular pattern of preventive dental services--a measure of access.

Newman JF, Gift HC.

Soc Sci Med. 1992 Oct;35(8):997-1001.

PMID:
1411707
25.

Oral health activities of U.S. children: results of a national health interview survey.

Gift HC, Newman JF.

J Am Dent Assoc. 1992 Oct;123(10):96-106.

PMID:
1401600
26.

Inhibition of the uncoating of bovine enterovirus by short chain fatty acids.

Ismail-Cassim N, Chezzi C, Newman JF.

J Gen Virol. 1990 Oct;71 ( Pt 10):2283-9.

PMID:
2172446
27.

Serum albumin beads possessing slow-release properties for vaccines.

Newman JF.

Adv Biotechnol Processes. 1990;14:129-46. Review. No abstract available.

PMID:
2222831
28.

Forty years of national public oral health data: continued value?

Newman JF.

J Public Health Dent. 1990 Fall;50(5):323-9. No abstract available.

PMID:
2121968
29.

Polymerized serum albumin beads possessing slow release properties for use in vaccines.

Martin ME, Dewar JB, Newman JF.

Vaccine. 1988 Feb;6(1):33-8.

PMID:
3128017
30.
31.

Myristylation of picornavirus capsid protein VP4 and its structural significance.

Chow M, Newman JF, Filman D, Hogle JM, Rowlands DJ, Brown F.

Nature. 1987 Jun 11-17;327(6122):482-6.

PMID:
3035380
33.
34.

Medical expenditures of terminal cancer patients during the last year of life.

Long SH, Gibbs JO, Crozier JP, Cooper DI Jr, Newman JF Jr, Larsen AM.

Inquiry. 1984 Winter;21(4):315-27.

PMID:
6240463
35.

The Providence Plan: prepaid health care for a voluntarily enrolled population.

Newman JF, Schreiber M, Gibbs JO.

Inquiry. 1983 Summer;20(2):134-41.

PMID:
6222984
36.

The Hospital Capitation Payment Project: new incentives and tools for cost containment.

Elliott WB, Strand HM, Meyers FH, Getson JR, Paulson C, Hill JE, Hennings MN, Newman JF, Raichel TM.

Inquiry. 1983 Summer;20(2):114-20.

PMID:
6222981
37.

The decline in the Blue Cross Plan admission rate: four explanations.

Lerner M, Salkever DS, Newman JF.

Inquiry. 1983 Summer;20(2):103-13.

PMID:
6222980
38.

Three is the magic number.

Newman JF.

Br Med J (Clin Res Ed). 1982 Jan 2;284(6308):23-4. No abstract available.

39.
40.

Attempts to control dental health care costs: the U.S. experience.

Gift HC, Newman JF, Loewy SB.

Soc Sci Med A. 1981 Dec;15(6):767-79. No abstract available.

PMID:
6798695
41.

Purification and identification of the RNA-dependent RNA polymerase of foot-and-mouth disease virus.

Newman JF, Cartwright B, Doel TR, Brown F.

J Gen Virol. 1979 Nov;45(2):497-507.

PMID:
232134
42.

Attempts of control health care costs: the United States experience.

Newman JF, Elliott WB, Gibbs JO, Gift HC.

Soc Sci Med. 1979 Aug;13A(5):529-40. No abstract available.

PMID:
472782
43.

In vitro translation of the Two RNAs of Nodamura virus, a novel mammalian virus with a divided genome.

Newman JF, Matthews T, Omilianowski DR, Salerno T, Kaesberg P, Rueckert R.

J Virol. 1978 Jan;25(1):78-85.

45.

Experience with retrospective medical audit in ambulatory care.

Burney RE, Newman JF.

Mil Med. 1978 Jan;143(1):29-31. No abstract available.

PMID:
414168
46.

Physicochemical characterization of two serologically unrelated equine rhinoviruses.

Newman JF, Rowlands DJ, Brown F, Goodridge D, Burrows R, Steck F.

Intervirology. 1977;8(3):145-54.

PMID:
67105
47.

Oligonucleotide mapping of picornavirus RNAs by two-dimensional electrophoresis.

Frisby DP, Newton C, Carey NH, Fellner P, Newman JF, Harris TJ, Brown F.

Virology. 1976 Jun;71(2):379-88. No abstract available.

PMID:
180657
48.

Absence of poly (A) from the infective RNA of Nodamura virus.

Newman JF, Brown F.

J Gen Virol. 1976 Jan;30(1):137-40.

PMID:
173797
49.

Characterisation of a rotavirus.20b.

Newman JF, Brown F, Bridger JC, Woode GN.

Nature. 1975 Dec 18;258(5536):631-3. No abstract available.

PMID:
173999
50.

The multiplication of Nodamura virus in insect and mammalian cell cultures.

Bailey L, Newman JF, Porterfield JS.

J Gen Virol. 1975 Jan;26(1):15-20.

PMID:
1168239

Supplemental Content

Loading ...
Support Center